Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study -

Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study
Information type: Other primary research
Source: The Lancet Diabetes & Endocrinology
Specialities: Cardiovascular system disorders | Diabetes
Summary
Analysis of 216,238 people followed up for a median of 9.7yrs reports patients with type 1 diabetes have a significantly increased risk for developing atrial fibrillation vs matched controls (HR 1.13, 95% CI 1.01–1.25, p=0.029 in men; and 1.50, 1.30–1.72, p<0.0001 in women).
UKMi comment

The study also reported worsening glycaemic control and renal insufficiency were particularly associated with the excess risk of incident atrial fibrillation.

In a related editorial, the authors discuss the findings of this study, suggesting that given the relation of diabetes duration and diabetic complications with atrial fibrillation and its complications, atrial fibrillation could be viewed as yet another manifestation of end-organ damage in diabetes.
Related links: Editorial